The ReBioStent project, led by U.K.-based Ceram, landed a $8 million (€5.8 million) grant to put towards developing new biomaterials and new arterial stents.
The ReBioStent project is seeking to develop biodegradable and biocompatible medical products, including stents. The 3-year project began this year and currently has 14 academy and industry partners working on it, according to a press release.
“At the end of this 3-year project, the group will have developed novel materials and new bioresorbable stents, helping to place the EU as a world leader in both biomaterials and stent design and development,” Ceram principal healthcare consultant Dr. Xiang Zhang said in prepared remarks.
Ceram is a consultancy company that tests and analyzes different materials and products, aiming to make production more efficient by finding errors and refining processes.